118 related articles for article (PubMed ID: 7523604)
21. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
22. Characterization of tenascin secreted by human melanoma cells.
Herlyn M; Graeven U; Speicher D; Sela BA; Bennicelli JL; Kath R; Guerry D
Cancer Res; 1991 Sep; 51(18):4853-8. PubMed ID: 1716515
[TBL] [Abstract][Full Text] [Related]
23. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins.
Friedlander DR; Zagzag D; Shiff B; Cohen H; Allen JC; Kelly PJ; Grumet M
Cancer Res; 1996 Apr; 56(8):1939-47. PubMed ID: 8620517
[TBL] [Abstract][Full Text] [Related]
24. Deoxythymidine-kinase in cerebrospinal fluid: a new potential "marker" for brain tumours.
Gronowitz JS; Källander CF; Hagberg H; Persson L
Acta Neurochir (Wien); 1984; 73(1-2):1-12. PubMed ID: 6093445
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
26. Regulation of astrocytic tenascin by basic fibroblast growth factor.
Meiners S; Marone M; Rittenhouse JL; Geller HM
Dev Biol; 1993 Dec; 160(2):480-93. PubMed ID: 7504635
[TBL] [Abstract][Full Text] [Related]
27. Detection of glioblastoma in biofluids.
Figueroa JM; Carter BS
J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
[TBL] [Abstract][Full Text] [Related]
28. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
29. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration.
Almeida SM; Cunha DS; Yamada E; Doi EM; Ono M
Arq Neuropsiquiatr; 2008 Sep; 66(3B):720-4. PubMed ID: 18949270
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases.
Ignatova N; Sindic CJ; Goffinet AM
Neurobiol Dis; 2004 Mar; 15(2):326-30. PubMed ID: 15006702
[TBL] [Abstract][Full Text] [Related]
31. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.
Ohnishi M; Matsumoto T; Nagashio R; Kageyama T; Utsuki S; Oka H; Okayasu I; Sato Y
Pathol Int; 2009 Nov; 59(11):797-803. PubMed ID: 19883430
[TBL] [Abstract][Full Text] [Related]
32. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
33. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma multiforme with epithelial differentiation: a potential diagnostic pitfall in cerebrospinal fluid cytology.
Gill SK; Padmanabhan V; Hickey WF; Marotti JD
Diagn Cytopathol; 2015 Aug; 43(8):638-41. PubMed ID: 25913842
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
36. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.
Sáez-Valero J; Costell M; Sjögren M; Andreasen N; Blennow K; Luque JM
J Neurosci Res; 2003 Apr; 72(1):132-6. PubMed ID: 12645087
[TBL] [Abstract][Full Text] [Related]
37. Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression.
Leprini A; Querzé G; Zardi L
Perspect Dev Neurobiol; 1994; 2(1):117-23. PubMed ID: 7530138
[TBL] [Abstract][Full Text] [Related]
38. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
39. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein.
Brodkey JA; Laywell ED; O'Brien TF; Faissner A; Stefansson K; Dörries HU; Schachner M; Steindler DA
J Neurosurg; 1995 Jan; 82(1):106-12. PubMed ID: 7529300
[TBL] [Abstract][Full Text] [Related]
40. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
